by Xcellerant Ventures | Jan 28, 2024 | Portfolio Company News
Origionally posted on MSN.com: https://www.msn.com/en-us/news/other/big-wins-strategic-moves-and-growth-for-ross-bundy%E2%80%99s-crispr-qc-and-gene-editing/ar-BB1hnksW?disableErrorRedirect=true&infiniteContentCount=0 The field of CRISPR editing has reached a...
by Xcellerant Ventures | Jan 24, 2024 | Portfolio Company News
Origionally posted on Biz Journals- AZ INNO:...
by Xcellerant Ventures | Jan 16, 2024 | Portfolio Company News
Origionally posted on PR Newswire: https://www.prnewswire.com/news-releases/dr-ghassan-kassab-joins-anuncia-medicals-board-elevating-future-product-innovation-302035828.html SCOTTSDALE, Ariz., Jan. 16, 2024 /PRNewswire/ — Anuncia Medical Inc....
by Xcellerant Ventures | Jan 12, 2024 | Portfolio Company News, Xcellerant Ventures News
Why Xcellerant Ventures Invested in CRISPR QC The Xcellerant Venture’s team is proud to lead a Series A funding round for CRISPR QC, the San Diego-based biotechnology company that has developed the world’s first and only CRISPR Analytics Platform. This platform...
by Xcellerant Ventures | Jan 9, 2024 | Portfolio Company News
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240109962697/en/TruLite-Health-Announces-Collaboration-with-Mayo-Clinic-to-Address-Clinical-Bias-Improve-Health-Equity TEMPE, Ariz.–(BUSINESS WIRE)–TruLite Health, developer of...